Comparing 2 hypotheses side-by-side
## Mechanistic Overview TREM2 R47H Variant Correction — AAV-Mediated Rescue of Common Risk Allele starts from the claim that modulating TREM2 within the disease context of Alzheimer's disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview TREM2 R47H Variant Correction — AAV-Mediated Rescue of Common Risk Allele starts from the claim that modulating TREM2 within the disease context of Alzheimer's disease can redirect a disease-relevant process. T
## Mechanistic Overview TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid Sensing and Clearance Deficits starts from the claim that modulating TREM2, APOE within the disease context of Alzheimer's disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview TREM2-APOE4 Co-targeting — Simultaneous Correction of Lipid Sensing and Clearance Deficits starts from the claim that modulating TREM2, APOE within the disease context of Alzheimer's dise
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
| Dimension | TREM2 R47H Variant Correction | TREM2-APOE4 Co-targeting — Sim |
|---|---|---|
| Mechanistic | 0.650 | 0.650 |
| Evidence | 0.700 | 0.670 |
| Novelty | 0.680 | 0.760 |
| Feasibility | 0.580 | 0.600 |
| Impact | 0.850 | 0.880 |
| Druggability | 0.600 | 0.600 |
| Safety | 0.580 | 0.580 |
| Competition | 0.550 | 0.550 |
| Data | 0.650 | 0.650 |
| Reproducible | 0.600 | 0.600 |
| KG Connect | 0.911 | 0.945 |
No evidence citations yet
No evidence citations yet
4 rounds · quality: 0.89
[MAX TOOL ROUNDS REACHED]...
I notice that you've mentioned "these hypotheses from the Theorist" but I don't see the actual hypotheses included in your message. It appears there may have been a previous conversation or document t...
I notice that your message mentions "these hypotheses" but the actual hypotheses aren't included in your request. It appears there may have been a previous conversation or the hypotheses were cut off....
I understand you want me to synthesize inputs from a Theorist, Skeptic, and Expert to produce final scored rankings of hypotheses. However, I notice that the actual hypotheses and the complete debate ...
4 rounds · quality: 0.89
[MAX TOOL ROUNDS REACHED]...
I notice that you've mentioned "these hypotheses from the Theorist" but I don't see the actual hypotheses included in your message. It appears there may have been a previous conversation or document t...
I notice that your message mentions "these hypotheses" but the actual hypotheses aren't included in your request. It appears there may have been a previous conversation or the hypotheses were cut off....
I understand you want me to synthesize inputs from a Theorist, Skeptic, and Expert to produce final scored rankings of hypotheses. However, I notice that the actual hypotheses and the complete debate ...
Curated mechanism pathway diagrams from expert analysis
graph TD
A["AAV Vector Delivery
Wild-type TREM2 cDNA
Microglial-specific promoter"] --> B["Transduction of
R47H Microglia
Nuclear delivery"]
B --> C["Wild-type TREM2
Expression
Membrane trafficking"]
C --> D["Functional TREM2
Surface presentation
Ligand binding domain"]
D --> E["Enhanced Lipid
Binding Capacity
Anionic surfaces and APOE"]
E --> F["TREM2-DAP12
Signaling Complex
Formation"]
F --> G["SYK and PI3K
Pathway Activation
Downstream cascades"]
G --> H["Disease-Associated
Microglia Transition
DAM phenotype"]
H --> I["Microglial Migration
to Amyloid Plaques
Chemotactic response"]
I --> J["Amyloid Plaque
Phagocytosis
Clearance mechanisms"]
J --> K["Reduced Amyloid
Burden
Plaque dissolution"]
H --> L["Anti-inflammatory
Cytokine Production
IL-10 and TGF-beta"]
L --> M["Neuroinflammation
Resolution
Tissue protection"]
M --> N["Synaptic Protection
and Maintenance
Neuronal integrity"]
K --> O["Cognitive Function
Preservation
Memory and learning"]
N --> O
P["Endogenous R47H
TREM2 Variant
Impaired function"] --> Q["Defective Amyloid
Clearance
Accumulation"]
Q --> R["Progressive
Neurodegeneration
Alzheimer pathology"]
classDef normal fill:#4fc3f7
classDef therapeutic fill:#81c784
classDef pathology fill:#ef5350
classDef outcome fill:#ffd54f
classDef molecular fill:#ce93d8
class A,B,C therapeutic
class D,E,F,G molecular
class H,I,J,L normal
class P,Q,R pathology
class K,M,N,O outcome
graph TD
A["Amyloid Beta
Plaques"] --> B["TREM2 Receptor
Lipid Ligand Binding"]
B --> C["DAP12 Adaptor
Phosphorylation"]
C --> D["SYK Kinase
Activation"]
D --> E["PI3K-mTOR
Signaling Cascade"]
E --> F["DAM Transcriptional
Program Activation"]
G["APOE4 Expression"] --> H["Impaired ABCA1
Cholesterol Efflux"]
H --> I["Deficient APOE
Lipidation"]
I --> J["Intracellular Lipid
Droplet Accumulation"]
J --> K["Lysosomal
Acidification Defect"]
K --> L["Phago-lysosomal
Maturation Block"]
F --> M["Frustrated DAM State
Activation without Function"]
L --> M
N["TREM2 Agonist
Therapy"] --> B
O["APOE4-to-APOE3
Correction"] --> P["Restored Lipid
Homeostasis"]
P --> Q["Functional Amyloid
Clearance Recovery"]
M --> R["Therapeutic Failure
in APOE4 Carriers"]
classDef normal fill:#4fc3f7
classDef therapeutic fill:#81c784
classDef pathology fill:#ef5350
classDef outcome fill:#ffd54f
classDef molecular fill:#ce93d8
class A,B,C,D,E pathology
class G,H,I,J,K,L pathology
class F,M pathology
class N,O therapeutic
class P,Q outcome
class R outcome